Last updated: February 20, 2026
Who are the primary producers of Modafinil?
Most pharmaceutical-grade Modafinil is produced by licensed pharmaceutical companies with global distribution rights. Key suppliers include:
- Cephalon (Teva Pharmaceutical Industries): Originally developed by Cephalon, now under Teva, they hold patents and regulatory approvals for commercial production.
- Sun Pharmaceutical Industries: A major generic manufacturer with authorized production for Modafinil in multiple markets.
- Dr. Reddy’s Laboratories: Produces generic versions mainly for Indian and global markets.
- Macleods Pharmaceuticals: Manufactures and supplies generic Modafinil for several countries.
- Aurobindo Pharma: Offers generic formulations of Modafinil for various regions.
Additional producers operate in countries where the drug is off-patent or not under strict patent protections, mainly producing generic forms.
Regulatory and licensing considerations
- United States: The FDA approves Modafinil under brand names like Provigil, produced by Cephalon/Teva.
- India: Several companies, including Sun and Dr. Reddy’s, are authorized to manufacture and distribute generics.
- Other Markets: Regional approvals depend on local drug authorities (e.g., EMA in Europe, TGA in Australia).
Key supply channels
- Pharmaceutical wholesalers: Distribute to hospitals, clinics, and pharmacies.
- Online pharmacies: Purchase directly from licensed manufacturers or authorized resellers, though regulatory oversight varies.
- Research chemicals suppliers: Sell Modafinil as a research chemical, often with disclaimers about non-medical use. These suppliers do not typically have regulatory approval for medicinal distribution.
Market dynamics
- Patent status: The patent for Provigil expired in 2012 in many markets, leading to an increase in generic manufacturers.
- Supply security: Concentrated among a few large manufacturers; supply disruptions are rare but possible due to regulatory issues or manufacturing problems.
- Quality assurance: Certificates of analysis (COA), Good Manufacturing Practice (GMP) compliance, and regulatory certifications are standard attributes of reputable suppliers.
Summary table of key suppliers
| Supplier |
Region of Operation |
Patent Status |
Notable Details |
| Cephalon/Teva |
Global |
Expired (patent expired 2012) |
Leading licensed manufacturer of Provigil |
| Sun Pharmaceutical Industries |
India, emerging markets |
Generic |
Major producer of affordable generics |
| Dr. Reddy’s Laboratories |
India, global |
Generic |
Widely available, certified manufacturing |
| Aurobindo Pharma |
Global |
Generic |
Competitive pricing, GMP-certified products |
| Macleods Pharmaceuticals |
India, export markets |
Generic |
Supplying to multiple regions |
Source highlights
- US FDA records confirm licensing and manufacturing restrictions for Provigil and generics (FDA, 2022).
- Patent expiration details are available through the U.S. Patent and Trademark Office and Indian patent office records.
- Industry reports detail market share and production capacities (IQVIA, 2021).
Key Takeaways
- Major suppliers include Teva (Cephalon), Sun, Dr. Reddy’s, Aurobindo, and Macleods.
- Patent status impacts market entry: generics proliferated after patent expiry in 2012.
- Quality standards and regulatory approval are critical factors for supply sourcing.
- Supply stability is concentrated among few large, GMP-certified manufacturers.
- Online and research chemical suppliers pose risks regarding product authenticity and legal compliance.
FAQs
Q1: Are all Modafinil suppliers FDA-approved?
No. Only licensed manufacturers like Teva and certain Indian firms hold FDA approval. Other suppliers may operate without FDA authorization.
Q2: How can I verify the authenticity of Modafinil?
Request Certificates of Analysis (COA), ensure GMP certification, and purchase from verified, licensed suppliers.
Q3: Is it legal to buy Modafinil online?
Legal status varies. In some countries, it requires a prescription. Verify local regulations before purchase.
Q4: What are the differences between branded and generic Modafinil?
Branded formulations like Provigil are manufactured by patent holders, often with higher costs. Generics contain the same active ingredient and are bioequivalent but usually cost less.
Q5: Has the patent expiration increased supply?
Yes. Post-2012 patent expiry, multiple generics became available, increasing overall supply and reducing prices.
References
- Food and Drug Administration. (2022). Approved drug products with therapeutic equivalence evaluations (Orange Book). Retrieved from https://www.accessdata.fda.gov
- IQVIA. (2021). Global pharmaceutical market analysis.
- U.S. Patent and Trademark Office. (2012). Patent expiration details for Provigil.
- Indian Patent Office. (2013). Patent status and generic manufacturing regulations.
